BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1281 related articles for article (PubMed ID: 19470732)

  • 21. Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling.
    Feuerstein I; Rainer M; Bernardo K; Stecher G; Huck CW; Kofler K; Pelzer A; Horninger W; Klocker H; Bartsch G; Bonn GK
    J Proteome Res; 2005; 4(6):2320-6. PubMed ID: 16335981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
    West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
    Leung SM; Pitts RL
    Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum peptidome profiling in patients with lung cancer.
    Yang J; Yang SY; Hu XY; Huo SF; Shang WL; Li ZF; Ni L; Wang AY; Guo YM; Song TS; Chen-Huang
    Anat Rec (Hoboken); 2010 Dec; 293(12):2027-33. PubMed ID: 21082738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool.
    Findeisen P; Peccerella T; Post S; Wenz F; Neumaier M
    Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1223-9. PubMed ID: 18348224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer.
    Lam YW; Mobley JA; Evans JE; Carmody JF; Ho SM
    Proteomics; 2005 Jul; 5(11):2927-38. PubMed ID: 15952230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.
    Callesen AK; Vach W; Jørgensen PE; Cold S; Tan Q; Depont Christensen R; Mogensen O; Kruse TA; Jensen ON; Madsen JS
    J Proteome Res; 2008 Apr; 7(4):1419-26. PubMed ID: 18303830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.
    Terracciano R; Pasqua L; Casadonte F; Frascà S; Preianò M; Falcone D; Savino R
    Bioconjug Chem; 2009 May; 20(5):913-23. PubMed ID: 19338374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of serum protein fingerprint model and support vector machine in diagnosis of thyroid cancer].
    Wang JX; Wang L; Fan YZ; Liu QL; Zhang J; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):979-82. PubMed ID: 16759540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases.
    Paradis V; Degos F; Dargère D; Pham N; Belghiti J; Degott C; Janeau JL; Bezeaud A; Delforge D; Cubizolles M; Laurendeau I; Bedossa P
    Hepatology; 2005 Jan; 41(1):40-7. PubMed ID: 15690480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer].
    Shi YJ; Zhao Y; Xu JM; Lai YH; Yu XZ; Zhong YS; Wei Y; Ren L; Zhu DX; Liu YK; Niu WX; Qin XY
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):910-3. PubMed ID: 19173991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of MALDI-TOF/MS identification of low-MW fragments in sera for the differential diagnosis of pancreatic cancer.
    Padoan A; Seraglia R; Basso D; Fogar P; Sperti C; Moz S; Greco E; Marchet A; de Manzoni G; Zambon CF; Navaglia F; Cristadoro L; Di Chiara A; Nitti D; Pedrazzoli S; Pavanello G; Plebani M
    Pancreas; 2013 May; 42(4):622-32. PubMed ID: 23271396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Identification of colorectal cancer using proteomic patterns in serum].
    Zhao G; Gao CF; Song GY; Li DH; Wang XL
    Ai Zheng; 2004 Jun; 23(6):614-8. PubMed ID: 15191657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on proteomics of familial systemic lupus erythematosus patients in one family from Sichuan, China].
    Wu YK; Huang ZC; Shi YY; Cai B; Wang LL; Ying BW; Hu CJ; Li YZ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):504-7, 512. PubMed ID: 19627015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of gastric cancer using decision tree classification of mass spectral data.
    Su Y; Shen J; Qian H; Ma H; Ji J; Ma H; Ma L; Zhang W; Meng L; Li Z; Wu J; Jin G; Zhang J; Shou C
    Cancer Sci; 2007 Jan; 98(1):37-43. PubMed ID: 17052262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of systemic lupus erythematosus.
    Huang Z; Shi Y; Cai B; Wang L; Wu Y; Ying B; Qin L; Hu C; Li Y
    Rheumatology (Oxford); 2009 Jun; 48(6):626-31. PubMed ID: 19389822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
    Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
    J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
    Findeisen P; Zapatka M; Peccerella T; Matzk H; Neumaier M; Schadendorf D; Ugurel S
    J Clin Oncol; 2009 May; 27(13):2199-208. PubMed ID: 19307507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry serum protein profiling.
    Lin XL; Yang SY; Du J; Tian YX; Bu LN; Huo SF; Wang FP; Nan YD
    Chin Med J (Engl); 2010 Jan; 123(1):34-9. PubMed ID: 20137572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.